Neuroimaging tools for presurgical brain mapping

Award Information
Agency: Department of Health and Human Services
Branch: National Institutes of Health
Contract: 2R42CA173976-02
Agency Tracking Number: R42CA173976
Amount: $1,589,364.00
Phase: Phase II
Program: STTR
Solicitation Topic Code: 102
Solicitation Number: PA14-072
Timeline
Solicitation Year: 2014
Award Year: 2015
Award Start Date (Proposal Award Date): 2015-07-01
Award End Date (Contract End Date): 2019-06-30
Small Business Information
890 ELM GROVE RD STE 215-2, Elm Grove, WI, 53122-2585
DUNS: 190899638
HUBZone Owned: N
Woman Owned: N
Socially and Economically Disadvantaged: N
Principal Investigator
 EDGAR DEYOE
 (414) 456-4920
 deyoe@mcw.edu
Business Contact
 PAUL SCHMELZER
Phone: (262) 754-3840
Email: pschmelzer@prismclinical.com
Research Institution
 MEDICAL COLLEGE OF WISCONSIN
 8701 WATERTOWN PLANK RD
MILWAUKEE, WI, 53226-3548
 Nonprofit college or university
Abstract
DESCRIPTION provided by applicant The goal of this project is to develop functional magnetic resonance imaging fMRI tools to assist the diagnosis and treatment of human patients with a brain tumor or other operable pathology The specific focus of this proposal is to produce a practical clinic ready suite of MR imaging methods analyses and display tools to solve the number one impediment to routine use of fMRI for guiding brain surgery and radiation treatment risk of brain damage due to the treatment itself Currently the primary clinical use of fMRI is to identify healthy brain tissue that might be damaged by surgery or radiation treatment and thereby cause an unintended neurological deficit such as partial blindness or paralysis Neurosurgeons who use fMRI for this purpose have reported that it allows them to be more aggressive in removing the tumor because they donandapos t have to guess where the healthy brain tissue is located However the success of using fMRI for this purpose depends on its ability to reliably distinguish between healthy brain tissue and diseased tissue that can be removed without causing a deficit Herein lies a critical problem fMRI signals are not generated by the brain cells themselves but rather by localized changes in blood flow and oxygenation that are triggered when the brain cells become active as the patient performs a sensory motor or cognitive task The cascade of cellular events that link changes in brain cell activity to changes in blood flow is complex and can be disrupted by a brain tumor or other disease process Disrupting this cascade causes andquot neurovascular uncouplingandquot NVU and results in a localized loss of the fMRI signal even though nearby brain cells are still functional If NVU is not detected healthy brain tissue can be mistaken for diseased tissue and inadvertently resected or irradiated This can result in treatment induced deficits such as partial loss of vision or limb movement Fortunately there are two promising methods that can be used to detect NVU but they have not been fully tested with patients nor have they been developed into tools that are ready for routine clinical use and distribution to the health care community Consequently the specific goal of this project is to address this need through a collaborative effort between imaging scientists and physicians at the Medical College of Wisconsin Johns Hopkins University and Prism Clinical Imaging Inc This Phase STTR project will address the feasibility of combining the two most promising methods testing the combined method with a small number of patients and developing prototype software for acquisition analysis and visualization of NVU related data Successful completion of this project will lead to a subsequent Phase project that will focus on testing a larger range of patients and pathologies and creating a commercial product ready for release to hospitals and clinics It is anticipated that the proposed technology will have a significant impact on the use of fMRI for guiding brain surgery and on the acceptance of fMRI as andquot standard of careandquot for this purpose PUBLIC HEALTH RELEVANCE The goal of this project is to develop functional magnetic resonance imaging fMRI tools to assist the diagnosis and treatment of human patients with a brain tumor or other operable pathology The specific focus of this proposal is to produce a practical clinic ready suite of MR imaging methods analyses and display tools to solve the number one impediment to routine use of fMRI for guiding brain surgery and radiation treatment risk of brain damage due to the treatment itself Currently the primary clinical use of fMRI is to identify healthy brain tissue that might be damaged by surgery or radiation treatment and thereby cause an unintended neurological deficit such as partial blindness or paralysis Neurosurgeons who use fMRI for this purpose have reported that it allows them to be more aggressive in removing the tumor because they donandapos t have to guess where the healthy brain tissue is located However the success of using fMRI for this purpose depends on its ability to reliably distinguish between healthy brain tissue and diseased tissue that can be removed without causing a deficit Herein lies a critical problem fMRI signals are not generated by the brain cells themselves but rather by localized changes in blood flow and oxygenation that are triggered when the brain cells become active as the patient performs a sensory motor or cognitive task The cascade of cellular events that link changes in brain cell activity to changes in blood flow is complex and can be disrupted by a brain tumor or other disease process Disrupting this cascade causes andquot neurovascular uncouplingandquot NVU and results in a localized loss of the fMRI signal even though nearby brain cells are still functional If NVU is not detected healthy brain tissue can be mistaken for diseased tissue and inadvertently resected or irradiated This can result in treatment induced deficits such as partial loss of vision or limb movement Fortunately there are two promising methods that can be used to detect NVU but they have not been fully tested with patients nor have they been developed into tools that are ready for routine clinical use and distribution to the health care community Consequently the specific goal of this project is to address this need through a collaborative effort between imaging scientists and physicians at the Medical College of Wisconsin Johns Hopkins University and Prism Clinical Imaging Inc This Phase STTR project will address the feasibility of combining the two most promising methods testing the combined method with a small number of patients and developing prototype software for acquisition analysis and visualization of NVU related data Successful completion of this project will lead to a subsequent Phase project that will focus on testing a larger range of patients and pathologies and creating a commercial product ready for release to hospitals and clinics It is anticipated that the proposed technology will have a significant impact on the use of fMRI for guiding brain surgery and on the acceptance of fMRI as andquot standard of careandquot for this purpose

* Information listed above is at the time of submission. *

Agency Micro-sites

SBA logo
Department of Agriculture logo
Department of Commerce logo
Department of Defense logo
Department of Education logo
Department of Energy logo
Department of Health and Human Services logo
Department of Homeland Security logo
Department of Transportation logo
Environmental Protection Agency logo
National Aeronautics and Space Administration logo
National Science Foundation logo
US Flag An Official Website of the United States Government